BeStock  
Stocks › Biotechnology › TBPH

Theravance Biopharma(Delisted) TBPH

US equityMarket cap rank #3323Biotechnology
$17.03 +$0.00 (0.00%)
Market closed · Oct 8, 12:00 am ET
Open$0.00
Prev close$17.03
Day range$0.00 – $0.00
Volume0.00
Market cap$884.18M
P/E (TTM)16.4
Dividend yield–

Earnings

Average move on report day±6.6%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+22.7%
Worst reaction-18.4%

Stock move on the day after each report

+2.3%2022/Q4+0.4%2023/Q1-0.9%2023/Q2+5.3%2023/Q3+5.0%2023/Q4-2.0%2024/Q1-18.4%2024/Q2+8.6%2024/Q3+2.1%2024/Q4-9.3%2025/Q1+4.2%2025/Q2+22.7%2025/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2025/Q310 Nov 2025After Market±22.0%+22.68%Bigger than priced
2025/Q212 Aug 2025After Market±14.1%+4.19%Within range
2025/Q18 May 2025After Market±9.5%-9.29%Within range
2024/Q426 Feb 2025After Market±22.1%+2.09%Within range
2024/Q312 Nov 2024After Market±13.8%+8.64%Within range
2024/Q25 Aug 2024After Market±12.3%-18.35%Bigger than priced
2024/Q113 May 2024After Market±7.8%-1.98%Within range
2023/Q426 Feb 2024After Market±17.6%+4.98%Within range
2023/Q37 Nov 2023After Market±6.7%+5.34%Within range
2023/Q27 Aug 2023After Market±9.7%-0.92%Within range
2023/Q18 May 2023After Market±13.7%+0.44%Within range
2022/Q427 Feb 2023After Market±19.6%+2.27%Within range
2022/Q37 Nov 2022After Market±6.5%+3.08%Within range
2022/Q24 Aug 2022After Market±16.6%-7.81%Within range
2022/Q15 May 2022None±15.4%-4.21%Within range
2021/Q423 Feb 2022None±29.6%+9.00%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$20.73M-20.9% YoY
Operating profit$1.84M+167.6% YoY
Net profit-$5.90M-110.8% YoY
Diluted EPS-$0.11-110.2% YoY
Free cash flow-$6.97M-103.3% YoY
Operating cash flow-$6.97M

Revenue, last 8 quarters

$16.9MSep '24$18.8MDec '24$15.4MMar '25$26.2MJun '25$20.0MSep '25$45.9MDec '25$17.7MMar '26$20.7MJun '26

Net profit, last 8 quarters

$-12.7MSep '24$-15.5MDec '24$-13.6MMar '25$54.8MJun '25$3.6MSep '25$61.0MDec '25$-4.9MMar '26$-5.9MJun '26

Profitability & balance sheet

Operating margin9.2%
Net margin51.6%
Return on equity20.9%
Return on assets12.0%
Return on invested capital14.0%
Current ratio13.54
Liabilities / assets38.3%
Cash & investments$387.66M
Total debt$27.77M
Net cash (debt)$359.88M
Free cash flow / sales51.5%

Discussion

No comments yet — be the first to weigh in on TBPH.

Leave a comment

Scroll to Top